Bayer Fights Indian Pharma's Bid To Nix Xarelto Patent
Pharma giant Bayer has hit back at an Indian company that had challenged its patent over its blood thinner Xarelto, saying its patent is valid and asking the court to bar...To view the full article, register now.
Already a subscriber? Click here to view full article